您当前位置：首页 > 国际期刊-CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL期刊投稿发表详细信息

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL Q3

期刊收录：
ESCI
Scopus
DOAJ

基本信息

期刊ISSN：
0011-393X
期刊简拼：
CURR THER RES CLIN E
年发文章数：
36
E-ISSN：
1879-0313
Gold OA文章占比
97.87%
研究文章占比：
83.33%
是否OA：
Yes
Jcr分区：
Q3
中科院分区：

出版信息

出版商：
Elsevier Inc.
涉及研究方向：
医学-药学
出版国家：
UNITED STATES
出版语言：
English
出版周期：
Bimonthly
出版年份：
1959

2023-2024最新影响因子:1.6
自引率:0.00%
五年影响因子:1.8
JCI期刊引文指标:0.41
h-index:34
CiteScore:3.50

期刊关键词

3区 ESCI Scopus DOAJ

期刊简介

We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics.

CTR encourages and supports the submission of manuscripts describing:

• Interventions designed to understand or improve human health, disease treatment or disease prevention;

• Studies that focus on problems that are uncommon in resource-rich countries;

• Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing);

• Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English;

• Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.

《CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL》期刊已被查看：次
期刊简写：CURR THER RES CLIN E

此期刊被最新的JCR期刊ESCI收录